DUBLIN--(BUSINESS WIRE)--Sep 11, 2018--The "Continuous Glucose Monitoring (CGM) Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering.

The global continuous glucose monitoring (CGM) market is projected to witness a CAGR of 20.71% during the forecast period to reach a total market size of US$3.916 billion by 2023, increasing from US$1.266 billion in 2017.

Continuous glucose monitoring devices are the latest advancement in the field of diabetes management.

The demand for continuous glucose monitoring devices is increasing for diagnosis and treatment of diabetes. In addition, a rise in the diabetic population is further contributing towards the growing demand for glucose monitoring devices.

Technological innovations, the convenience of the monitoring device, the early detection of hypoglycaemia and hyperglycaemic diabetes are some of the major drivers boosting the growth of this market. However, high prices of these devices and calibration issues will restrict the market growth over the forecast period.

Key Topics Covered

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Currency

1.5. Assumptions

1.6. Base and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design

2.2. Secondary Sources

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1. Market Segmentation

4.2. Market Drivers

4.3. Market Restraints

4.4. Market Opportunities

4.5. Porter's Five Force Analysis

4.6. Life Cycle Analysis - Regional Snapshot

4.7. Market Attractiveness

5. CONTINUOUS GLUCOSE MONITORING (CGM) MARKET BY APPLICATION

5.1. Diabetic Patients

5.2. Critical Care Patients

6. CONTINUOUS GLUCOSE MONITORING (CGM) MARKET BY END USER

6.1. Hospitals

6.2. Diagnostic Centers and Clinics

6.3. Home Care

7. CONTINUOUS GLUCOSE MONITORING (CGM) MARKET BY GEOGRAPHY

7.1. North America

7.2. South America

7.3. Europe

7.4. Middle East and Africa

7.5. Asia Pacific

8. COMPETITIVE INTELLIGENCE

8.1. Market Share Analysis

8.2. Investment Analysis

8.3. Recent Deals

8.4. Strategies of Key Players

9. COMPANY PROFILES

9.1. Dexcom, Inc.

9.2. Abbott Laboratories

9.3. Medtronic Pvt. Ltd.

9.4. GlySens Incorporated

9.5. Animas Corporation

9.6. Senseonics

9.7. GlySure

9.8. Biorasis

For more information about this report visit https://www.researchandmarkets.com/research/6nn774/continuous?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180911005720/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T. Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Glucose Testing,Diabetes Devices ,Wearable Technology

KEYWORD:

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES DIABETES

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/11/2018 02:12 PM/DISC: 09/11/2018 02:12 PM

http://www.businesswire.com/news/home/20180911005720/en